ZYVERSA THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -14.1% | -14.1% | -11.9% |
| FY2023 | -887.6% | -887.6% | -444.5% |
| FY2024 | -110.5% | -110.5% | -45.7% |
| FY2025 | 201.4% | 201.4% | -7,172.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -14.1% | -14.1% | -11.9% |
| FY2023 | -887.6% | -887.6% | -444.5% |
| FY2024 | -110.5% | -110.5% | -45.7% |
| FY2025 | 201.4% | 201.4% | -7,172.3% |